-
Published 7/7/2022
Kempf AM, Burns ZT, Guss CE, Millington K, Pilcher S, Boyle PJ, Charlton BM, Haas-Kogan DA, Liu KX. Clinical outcomes and considerations of gender-affirming care for transgender and gender-diverse pediatric and young adult patients with cancer. Pediatr Blood Cancer. 2023 Jan; 70(1):e29851. PMID: 35713118.
-
Published 3/10/2022
Krebs D, Harris RM, Steinbaum A, Pilcher S, Guss C, Kremen J, Roberts SA, Baskaran C, Carswell J, Millington K. Care for Transgender Young People. Horm Res Paediatr. 2022; 95(5):405-414. PMID: 35272283.
-
Published 3/1/2022
Barrera E, Millington K, Kremen J. The Medical Implications of Banning Transgender Youth From Sport Participation. JAMA Pediatr. 2022 03 01; 176(3):223-224. PMID: 34870701.
-
Published 1/26/2022
Millington K, Barrera E, Daga A, Mann N, Olson-Kennedy J, Garofalo R, Rosenthal SM, Chan YM. The effect of gender-affirming hormone treatment on serum creatinine in transgender and gender-diverse youth: implications for estimating GFR. Pediatr Nephrol. 2022 Sep; 37(9):2141-2150. PMID: 35083530.
-
Published 12/21/2021
Pollock NI, Flamand Y, Zhu J, Millington K, Stevenson K, Silverman LB, Vrooman LM, Cohen LE. Hyperglycemia during induction therapy for acute lymphoblastic leukemia is temporally linked to pegaspargase administration. Pediatr Blood Cancer. 2022 07; 69(7):e29505. PMID: 34931744.